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To the Editor: Active surveillance for zoonotic patho-
gens in wildlife is particularly critical when the pathogen 
has the potential to cause a large-scale outbreak. The recent 
outbreak of Ebola virus (EBOV) disease in West Africa in 
2014 was initiated by a single spillover event, followed by 
human-to-human transmission (1). Projection of filovirus 
ecologic niches suggests possible areas of distribution in 
Southeast Asia (2). Reston virus was discovered in ma-
caques exported from the Philippines to the United States 
in 1989 and in sick domestic pigs in the Philippines in 2008 
(with asymptomatic infection in humans) (3). Dead insec-
tivorous bats in Europe were found to be infected by a filo-
virus, similar to other members of the genus Ebolavirus (4).
Although EBOV has historically been viewed as a vi-
rus from Africa, recent studies found that bat populations 
in Bangladesh and China contain antibodies against EBOV 
and Reston virus recombinant proteins, which suggests that 
EBOVs are widely distributed throughout Asia (5,6). Thus, 
an outbreak in Asian countries free of EBOV diseases may 
not only be caused by importation of infected humans 
and/or wildlife from Africa but may arise from in-country 
filovirus–infected wildlife. Serologic and molecular evi-
dence for filoviruses suggests that members of the order 
Chiroptera (bats) may be their natural reservoir (7).
As part of a proactive biosurveillance program, we 
conducted a cross-sectional study for EBOV infection in 
bats and macaques in Thailand. We screened 500 Pteropus 
lylei bats collected from 10 roosting sites during March–
June 2014 (online Technical Appendix, http://wwwnc.cdc.
gov/EID/article/20/12/15-0860-Techapp1.pdf) for antibod-
ies against EBOV antigen by using an ELISA validated by 
the Centers for Disease Control and Prevention (Atlanta, 
GA, USA) (8).
Bats and macaques were captured with permission from 
the Department of National Parks, Wildlife and Plant Con-
servation. The Institutional Animal Care and Use Committee 
at the University of California, Davis (protocol #16048) ap-
proved the capture and sample collection protocols.
To further screen a wide range of wildlife species in 
Thailand for active EBOV infection, we sampled and tested 
699 healthy bats, representing 26 species, and 50 long-tailed 
macaques (Macaca fascicularis). Additional bat species were 
randomly captured (≥50/site) in 6 provinces in Thailand dur-
ing 2011–2013 and identified by morphologic traits. Ma-
caques were captured and sampled in March 2013 from 1 site 
at Khao Chakan, Sa Kaeo Province, and released at the same 
site. Blood, saliva, urine, and feces were collected from anes-
thetized macaques or nonanesthetized bats. All animals were 
released after sample collection. Details on species screened, 
sample sizes, and trapping localities are provided in the Table. 
All nonblood specimens were collected in nucleic 
acid extraction buffer (lysis buffer) and transported on ice 
to the World Health Organization Collaborating Centre 
for Research and Training on Viral Zoonoses laboratory 
(Bangkok, Thailand) for storage and testing. Three types 
of specimen (saliva, urine, and serum) were collected from 
individual animals and pooled.
Nucleic acid was then extracted with NucliSENS easy-
MAG (bioMérieux, Boxtel, the Netherlands) and analyzed 
by reverse transcription PCR (RT-PCR). A consensus RT-
PCR was used to screen for all known species of Ebola vi-
rus and Marburg virus, including EBOV (9). In total, 5 RT-
PCRs were performed on each specimen, a regimen that 
included 4 sets of primers specific to known filoviruses and 
1 degenerate primer set to detect novel viruses in this fam-
ily. The sensitivity of RT-PCR on synthetic standard was 
50–500 copies/reaction (9). We ran 3,745 PCRs, covering a 
range of assays, to increase detection sensitivity. All speci-
mens examined were negative for filoviruses by EBOV 
ELISA and PCR (Table). For P. lylei ELISA screening, op-
tical density values for all 500 bats ranged from 0.000 to 
0.095, well below the potential positive cutoff value of 0.2. 
Assuming a population size of ≈5,000 bats/roost and 
a sample size of 50 bats/site, we have 95% confidence that 
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if >6% of the population had antibodies against EBOV 
antigen, we would have detected it. If we assume that all 
500 animals are part of 1 large panmictic population, and 
we have 95% confidence that if EBOV were circulating in 
>0.5% of the population, we would have detected it. There-
fore, although we cannot rule out infection of this species 
with 100% confidence, P. lylei bats, the most abundant spe-
cies of large pteropid bats in Thailand, are highly unlikely 
to be reservoirs for EBOV. 
Our sample sizes for PCR screening of other bat 
species in this study were much smaller, and we had no 
supported serologic data, but these negative results could 
add to the knowledge of filovirus infection in nontissue 
specimens from healthy bats. Previous studies have de-
tected Ebola virus–like filovirus RNA in lung tissue of 
healthy Rousettus leschenaultia bats in China (10) and 
from organs and throat and rectal swab specimens from 
a die-off of Miniopterus schreibersii bats in Spain (4). In 
our study, which included 22 M. schreibersii and 132 M. 
magnate bats, none of the bats tested positive for filovi-
ruses.One limitation of the cross-sectional sampling strat-
egy used here, however, is that PCR-negative findings 
do not necessarily mean that the bats were not infected 
in the past. Although we found no evidence of filovirus 
infection in wildlife species tested in Thailand, we believe 
that continuing targeted surveillance in wildlife should 
enable early detection and preparedness to preempt 
emerging zoonoses.
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Table. Overview of bats and macaques tested by Ebola virus IgG ELISA or PCR for filoviruses, Thailand, 2011–2014 
Species Host family No. tested (no. positive) Test method* Specimen type† Location‡ 
Chiroptera      
 Pteropus lylei Pteropodidae 500 (0) ELISA Serum a 
 Cynopterus brachyotis Pteropodidae 10 (0) PCR Pooled b 
 C. sphinx Pteropodidae 4 (0) PCR Pooled b 
 Eonycteris spelaea Pteropodidae 12 (0) PCR Pooled b 
 Macroglossus sobrinus Pteropodidae 2 (0) PCR Pooled b 
 Megaerops niphanae Pteropodidae 1 (0) PCR Pooled b 
 Rousettus amplexicaudatus Pteropodidae 3 (0) PCR Pooled b 
 Hipposideros armiger Hipposideridae 113 (0) PCR Pooled b 
 H. cineraceus Hipposideridae 4 (0) PCR Pooled b 
 H. larvatus Hipposideridae 33 (0) PCR Pooled b, c 
 H. lekaguli Hipposideridae 158 (0) PCR Pooled b 
 Megaderma lyra Megadermatidae 1 (0) PCR Pooled b 
 Miniopterus magnate Vespertilionidae 132 (0) PCR Pooled b, c 
 M. pusillus Vespertilionidae 1 (0) PCR Pooled b 
 M. schreibersii Vespertilionidae 22 (0) PCR Pooled b 
 Myotis horsfieldi Vespertilionidae 6 (0) PCR Pooled b 
 M. muricola Vespertilionidae 1 (0) PCR Pooled b 
 Rhinolophus shameli Rhinolophidae 44 (0) PCR Pooled b 
 R. coelophyllus Rhinolophidae 7 (0) PCR Pooled c 
 R. luctus Rhinolophidae 1 (0) PCR Pooled b 
 R. malayanus Rhinolophidae 4 (0) PCR Pooled c 
 R. microglobosus Rhinolophidae 1 (0) PCR Pooled b 
 R. pusillus Rhinolophidae 1 (0) PCR Pooled b 
 Scotophilus kuhlii Vespertilionidae 1 (0) PCR Pooled b 
 Taphozous longimanus Emballonuridae 27 (0) PCR Pooled b 
 T. melanopogon Emballonuridae 110 (0) PCR Pooled b 
 Total  699 (0)    
 Primate      
 Macaca fascicularis Cercopithecidae 50 (0) PCR Pooled d 
*ELISA for IgG against Ebola virus. 
†Nucleic acid extraction from Pooled saliva, serum, and urine. 
‡a, Central Thailand; b, Eastern Thailand; c, Chaing Mai Province; d, Kao Chakan, Sa Kaeo Province. 
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To the Editor: Borreliosis caused by Borrelia miyamo-
toi is an emerging disease transmitted by Ixodes ticks (1). 
Each year in the Netherlands during 2007–2009, ≈70,000 
bites by hard ticks occurred per 1 million inhabitants (2). 
In the Republic of Udmurtia, Russia, ≈10,000 hard tick 
bites per 1 million inhabitants are reported annually among 
persons seeking medical help. Recent studies indicate that 
almost 3% of I. ricinus ticks in the Netherlands and 2%–6% 
of I. persulcatus ticks in Russia are infected with B. miya-
motoi (1,3,4). Human exposure is substantial, and compara-
ble exposure to B. miyamotoi is expected in many Eurasian 
countries and in North America (4,5). The probability of 
B. miyamotoi transmission from ticks to humans requires 
examination to estimate the true risk for human disease.
In Izhevsk (population 650,000), a city in European 
Russia (Republic of Udmurtia), we identified 95 human 
cases of B. miyamotoi infection during 2010–2014 (6). 
In this city, primarily because of concern about tickborne 
encephalitis (TBE), all patients with suspected tickborne 
infection are hospitalized in the Republican Hospital of 
Infectious Diseases (RHID). A service also enables tick-
bitten persons to bring the removed tick for PCR for TBE 
virus (TBEV) and B. burgdorferi sensu lato. We supple-
mented that with PCR testing for B. miyamotoi (3).
In June 2014, twenty-four persons (≈5% of those bitten 
by ticks subjected to PCR-based investigation for TBEV, B. 
burgdorferi sensu lato, and B. miyamotoi) were bitten by 
adult I. persulcatus ticks infected with B. miyamotoi only. 
We informed these persons of their results and about the 
clinical features of B. miyamotoi infection and recommend-
ed self-observation during 2 months (twice the maximum 
incubation period for B. miyamotoi infection [3,6]). These 
persons were advised to contact their medical supervisor at 
RHID (D.S. Sarksyan) if fever, fatigue, erythema migrans, 
or any other possible symptom of a tickborne infection de-
veloped. In 2 patients, such symptoms developed: one 12 
days (patient 1), the other 16 days (patient 2), after the tick 
bite. B. miyamotoi DNA was detected by PCR in their blood 
on admission to RHID. Neither IgM nor IgG were found by 
a nonspecific ELISA (Omnix, St. Petersburg, Russia [7]) 
that reacts with serum from B. burgdorferi sensu lato–in-
fected and B. miyamotoi–infected persons. However, Bor-
relia IgM and IgG were detected in serum obtained 12 
and 45 days after illness onset from patient 1 and 6 and 39 
days later from patient 2. Clinical characteristics were typi-
cal of B. miyamotoi infection: chills, sweating, headache, 
dizziness, fatigue, thirst, nausea, vomiting, fever (axillar 
temperature 38.8°C in patient 1 and 39.0°C in patient 2). 
Erythema migrans was absent. Both patients had modest 
thrombocytopenia (134 [patient 1] and 118 [patient 2] × 109 
platelets/mL [reference range 150–400 × 109 platelets/mL]) 
and increased band neutrophils (10% [patient 1] and 8% 
[patient 2] of leukocytes [reference range 1%–5%]). Pa-
tient 2 had clinical and laboratory signs of kidney dysfunc-
tion (oliguria, leukocytes, erythrocytes, and epithelial cells 
in a urine sample), a complication observed in 18% of 95 
patients with B. miyamotoi disease (4). Both patients were 
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